Look into hepatic progenitor cell associated trait: Histological heterogeneity of hepatitis B-related combined hepatocellular-cholangiocarcinoma

Abstract

Combined hepatocellular-cholangiocarcinoma (CHC) is a mixed tumor containing elements of both hepatocellular carcinoma (HCC) and cholangiocarcinoma (CC). Its remarkable histological heterogeneity has been linked to putative hepatic progenitor cell (HPC) origin. However, detailed histological or phenotypic description is rarely documented. In the present study, we reassessed 68 cases previously diagnosed as hepatitis B-related CHCs by immunohistochemistry and double-fluorescence immunostaining, focusing on HPC associated phenotypic observation of intermediate area of the tumor. It was found that tumor cells showed remarkable heterogeneity in intermediate area. Tumor cells with intermediate morphology between hepatocytes and cholangiocytes were oval-shaped and small with scant cytoplasm and hyperchromatic nuclei, arranging in solid nests mostly. By Keratin 7 (K7) staining, it appeared that the nests of tumor cells represented a maturation process from the undifferentiated small cells to mature hepatocytes through the “transitional” cells. Then, these small cells were further confirmed with intermediate phenotype as HPC by exploring immature hepatocellular marker and HPC/biliary markers co-localization. In conclusion, the HPC associated trait in CHC can be interpreted by HPC origin or gain of “stemness” by dedifferentiation. It is still too soon to give a final word that it is innate or acquired signature of HPC associated trait in CHC.

Keywords

human / cholangiohepatoma / progenitor / heterogeneity / histology

References

[1] GoodmanZD, IshakKG, LanglossJM, et al. . Combined hepatocellular-cholangiocarcinoma. A histologic and immunohistochemical study. Cancer, 1985, 55(1): 124-135 PMID: 2578078

[2] TheiseND, NakashimaO, ParkYN, et al. . BosmanFT, CarneiroF, HrubanRH, TheiseND, et al. . Combined hepatocellular-cholangiocarcinoma. WHO classification of tumours of the digestive system, 20104Lyon, International Agency for Research on Cancer, 225-227

[3] WittekindC, FischerHP, PonchonT. HamiltonSR, AaltonenLA. Combined hepatocellular and cholangiocarcinoma. Pathology and genetics of tumours of the digestive system, 2000, Lyon, International Agency for Research on Cancer, 181

[4] TheiseND, YaoJL, HaradaK, et al. . Hepatic “stem cell” malignancies in adults: four cases. Histopathology, 2003, 43(3): 263-271 PMID: 12940779

[5] ZhangF, ChenXP, ZhangW, et al. . Combined hepatocellular cholangiocarcinoma originating from hepatic progenitor cells: immunohistochemical and doublefluorescence immunostaining evidence. Histopathology, 2008, 52(2): 224-232 PMID: 18184271

[6] HrubanRH, AskinFB. Surgical pathology dissection: an illustrated guide, 1996, New York, Springer

[7] CarsonF, HladikC. Histotechnology: A Self-Instructional Text, 20093Chicago, IL, American Society for Clinical Pathology Press

[8] MaedaT, AdachiE, KajiyamaK, et al. . Combined hepatocellular and cholangiocarcinoma: proposed criteria according to cytokeratin expression and analysis of clinicopathologic features. Hum Pathol, 1995, 26(9): 956-964 PMID: 7545644

[9] CaiX, ZhaiJ, KaplanDE, et al. . Background progenitor activation is associated with recurrence after hepatectomy of combined hepatocellular-cholangiocarcinoma. Hepatology, 2012, 56(5): 1804-1816 PMID: 22684921 PMCID: 4586114

[10] KomutaM, SpeeB, Vander BorghtS, et al. . Clinicopathological study on cholangiolocellular carcinoma suggesting hepatic progenitor cell origin. Hepatology, 2008, 47(5): 1544-1556 PMID: 18393293

[11] BruntEM, ParadisV, SempouxC, et al. . Biphenotypic (hepatobiliary) primary liver carcinomas: the work in progress. Hepatic Oncology, 2015, 2(3): 255-273 PMID: 30191007 PMCID: 6095308

[12] AkibaJ, NakashimaO, HattoriS, et al. . Clinicopathologic analysis of combined hepatocellular-cholangiocarcinoma according to the latest WHO classification. Am J Surg Pathol, 2013, 37(4): 496-505 PMID: 23388123

[13] HanahanD, WeinbergRA. Hallmarks of cancer: the next generation. Cell, 2011, 144(5): 646-674 PMID: 21376230

[14] Friedmann-MorvinskiD, VermaIM. Dedifferentiation and reprogramming: origins of cancer stem cells. EMBO Rep, 2014, 15(3): 244-253 PMID: 24531722 PMCID: 3989690

[15] KimH, ParkYN. Hepatocellular carcinomas expressing “stemness”-related markers: clinicopathological characteristics. Dig Dis, 2014, 32(6): 778-785 PMID: 25376296

[16] SeokJY, NaDC, WooHG, et al. . A fibrous stromal component in hepatocellular carcinoma reveals a cholangiocarcinoma-like gene expression trait and epithelialmesenchymal transition. Hepatology, 2012, 55(6): 1776-1786 PMID: 22234953

[17] HolczbauerA, FactorVM, AndersenJB, et al. . Modeling pathogenesis of primary liver cancer in lineage-specific mouse cell types. Gastroenterology, 2013, 145(1): 221-231 PMID: 23523670 PMCID: 3913051

[18] LeeJS, HeoJ, LibbrechtL, et al. . A novel prognostic subtype of human hepatocellular carcinoma derived from hepatic progenitor cells. Nat Med, 2006, 12(4): 410-416 PMID: 16532004

[19] KimH, ChoiGH, NaDC, et al. . Human hepatocellular carcinomas with “Stemness”-related marker expression: keratin 19 expression and a poor prognosis. Hepatology, 2011, 54(5): 1707-1717 PMID: 22045674

[20] YamashitaT, ForguesM, WangW, et al. . EpCAM and alpha-fetoprotein expression defines novel prognostic subtypes of hepatocellular carcinoma. Cancer Res, 2008, 68(5): 1451-1461 PMID: 18316609

[21] YamashitaT, JiJ, BudhuA, et al. . EpCAM-positive hepatocellular carcinoma cells are tumor-initiating cells with stem/progenitor cell features. Gastroenterology, 2009, 136(3): 1012-1024 PMID: 19150350

[22] OikawaT, WauthierE, DinhTA, et al. . Model of fibrolamellar hepatocellular carcinomas reveals striking enrichment in cancer stem cells. Nat Commun, 2015, 6: 8070 PMID: 26437858 PMCID: 4600730

[23] ZeunerA, TodaroM, StassiG, et al. . Colorectal cancer stem cells: from the crypt to the clinic. Cell Stem Cell, 2014, 15(6): 692-705 PMID: 25479747

[24] MedemaJP. Cancer stem cells: the challenges ahead. Nat Cell Biol, 2013, 15(4): 338-344 PMID: 23548926

[25] ThorgeirssonSS. Stemness and reprogramming in liver cancer. Hepatology, 2016, 63(4): 1068-1070 PMID: 26600290

[26] NaultJC, Zucman-RossiJ. Genetics of hepatocellular carcinoma: the next generation. J Hepatol, 2014, 60(1): 224-226 PMID: 23994386

[27] RoskamsT. Liver stem cells and their implication in hepatocellular and cholangiocarcinoma. Oncogene, 2006, 25(27): 3818-3822 PMID: 16799623

[28] VisvaderJE. Cells of origin in cancer. Nature, 2011, 469(7330): 314-322 PMID: 21248838

[29] WakasaT, WakasaK, ShutouT, et al. . A histopathological study on combined hepatocellular and cholangiocarcinoma: cholangiocarcinoma component is originated from hepatocellular carcinoma. Hepatogastroenterology, 2007, 54(74): 508-513 PMID: 17523309

[30] Zucman-RossiJ, NaultJC, ZenderL. Primary liver carcinomas can originate from different cell types: a new level of complexity in hepatocarcinogenesis. Gastroenterology, 2013, 145(1): 53-55 PMID: 23726876

[31] FanB, MalatoY, CalvisiDF, et al. . Cholangiocarcinomas can originate from hepatocytes in mice. J Clin Invest, 2012, 122(8): 2911-2915 PMID: 22797301 PMCID: 3408746